敏实集团(00425)再涨超4%，截至发稿，涨4.04%，报37.6港元，成交额4504.98万港元。 消息面上，敏实集团日前公告，公司附属公司精确实业已于近期自一间台湾AI服务器厂商获得订单， 据此精确实业将按照客户规格要求进行AI服务器浸没式液冷柜的设计、开发及生产。截至公告日期， 精确实业已通过该客户针对浸没式液冷柜的技术验证。相关产品预计将于2025年11月中旬开始分批交 付。此外，截至公告日期，集团亦已通过另一间台湾AI服务器液冷系统厂商的分水器技术验证，并获 取相关订单，首批产品预计将于2025年12月底前进行交付。 开源证券此前指，公司是全球领先的汽车外饰件和车身结构件供应商，已形成塑件、金属及饰件、铝件 和电池盒四大产品线，客户涵盖全球知名整车厂。公司传统业务增长较为稳健，电池盒业务受益于欧洲 电动车放量，有望贡献利润弹性，且公司已形成较为全面的全球产能布局，构筑产能壁垒。此外，公司 积极开拓低空、机器人、AI液冷等新赛道，有望形成第三成长曲线。 ...

Group 1: AI Server Liquid Cooling - The liquid cooling industry is expected to replicate the performance of optical modules in the next two years, potentially becoming the fastest-growing segment in the AI industry chain [1][2] - Liquid cooling is currently in its nascent stage, with a projected penetration rate of nearly 100% for overseas NV chain servers by next year, indicating rapid growth [2] - The growth rate for AI server liquid cooling could reach 500% next year, significantly outpacing other segments like optical modules and PCBs [1][2] Group 2: Market Perception and Valuation - The market's current pricing of AI computing power reflects a fundamental misjudgment, applying a cyclical stock valuation framework to a technology revolution [1] - Nvidia's guidance of a 40%-50% compound annual growth rate suggests that AI computing power could justify valuations of 40-50 times earnings, indicating a potential revaluation of the sector [1] - The overall AI industry is expected to maintain growth until 2030, driven by both increased penetration rates and higher unit value [2] Group 3: Innovation in Pharmaceuticals - The Chinese innovative drug sector is in a multi-year upward trend, driven by the "BD going overseas" strategy, with significant opportunities arising from the expiration of patents for major multinational pharmaceutical companies [3][4] - The strength of the research pipeline for Chinese innovative drug companies is improving, particularly in the PD-1/VEGF and PD-1/IL-2 dual antibody fields [3] - Current valuations in the innovative drug sector are considered normal, without signs of a bubble, contrasting sharply with the exaggerated valuations seen during the 2019-2021 bull market [4][5] Group 4: Future Outlook - The optical module sector may enter a phase of consolidation after a significant rally, while liquid cooling is positioned to take over as the next key investment opportunity in AI [5] - The innovative drug sector is expected to resume its upward momentum as key catalysts, such as global academic conferences, approach [5]